Related Experiment Video
Updated: Jul 16, 2025

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
CROI 2023: Metabolic and Other Complications of HIV Infection
1Johns Hopkins University, Baltimore, Maryland, USA.
Insights
Comorbidities significantly impact aging individuals with HIV, affecting health and survival. Research at CROI 2023 explored cardiovascular disease, cancer, and obesity, focusing on treatment impacts.
Area of Science:
- HIV/AIDS research
- Cardiovascular disease (CVD)
- Cancer epidemiology
- Obesity and metabolic disorders
Background:
- Comorbid conditions significantly affect the health, quality of life, and survival of aging people with HIV.
- The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) highlighted critical research on comorbidities in this population.
Approach:
- Review of scientific abstracts presented at CROI 2023 focusing on cardiovascular disease, cancer, and obesity in people with HIV.
- Analysis of studies investigating contributing factors to CVD, including mental health, antiretroviral therapies (ART), and hormonal pathways.
- Examination of research on the epidemiology of non-AIDS-defining cancers and the impact of ART on weight gain.
Key Points:
- CVD research explored links to mental health, ART, and hormonal factors.
- Epidemiology of non-AIDS-defining cancers in people with HIV was a key focus.
- Weight gain associated with ART and potential weight reduction after ART discontinuation were significant themes.
Conclusions:
- CROI 2023 showcased critical advancements in understanding and managing comorbidities in aging people with HIV.
- The findings have significant clinical implications for improving long-term health outcomes and quality of life.
Abstract:
Comorbid conditions have major impacts on the health, quality of life, and survival of people with HIV, particularly as they age. The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) featured excellent science related to specific comorbidities, such as cardiovascular disease (CVD), cancer, and obesity. Studies investigating factors that may contribute to CVD, such as mental health disorders, antiretroviral therapies, and activation of hormonal pathways, were featured prominently. Other studies sought to understand the epidemiology of non-AIDS-defining cancers in people with HIV. As at previous CROI conferences, weight gain attributable to antiretroviral therapies was a major theme, and several abstracts focused on the important question of whether weight decreases after discontinuation of antiretroviral therapy (ART) regimens associated with weight gain. This review focuses on abstracts presented at CROI 2023 in these areas, highlighting those with the most clinical impact.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Diabetes: Symptoms, Diagnosis, and Complications
Chronic Kidney Disease II: Clinical Manifestations
Hemodialysis II: Procedure and Complications
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Sexually Transmitted Infections

